Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.16.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ML.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-21367.3US
KP.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.99NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used